Early safety assessment using cellular systems biology yields insights into mechanisms of action.
The integration of high-content screening (HCS) readers with organ-specific cell models, panels of functional biomarkers, and advanced informatics is a powerful approach to identifying the toxic liabilities of compounds early in the development process and forms the basis of "early safety assessment." This cellular systems biology (CSB) approach (CellCiphr profile) has been used to integrate rodent and human cellular hepatic models with panels of functional biomarkers measured at multiple time points to profile both the potency and specificity of the cellular toxicological response. These profiles also provide initial insights on the mechanism of the toxic response. The authors describe here mechanistic assay profiles designed to further dissect the toxic mechanisms of action and elucidate subtle effects apparent in subpopulations of cells. They measured 8 key mechanisms of toxicity with multiple biomarker feature measurements made simultaneously in populations of living primary hepatocytes and HepG2 cells. Mining the cell population response from these mechanistic profiles revealed the concentration dependence and nature of the heterogeneity of the response, as well as relationships between the functional responses. These more detailed mechanistic profiles define differences in compound activities that are not apparent in the average population response. Because cells and tissues encounter wide ranges of drug doses in space and time, these mechanistic profiles build on the CellCiphr profile and better reflect the complexity of the response in vivo.
Giuliano
Kenneth A
KA
Cellumen, Inc., Pittsburgh, PA, USA. kgiuliano@cellumen.com
Gough
Albert H
AH
Taylor
D Lansing
DL
Vernetti
Lawrence A
LA
Johnston
Patricia A
PA
D000818:Animals; D001681:Biological Assay; D015415:Biomarkers / Q000378:metabolism; D002463:Cell Membrane Permeability / Q000187:drug effects; D064420:Drug-Related Side Effects and Adverse Reactions / Q000175:diagnosis*; D056945:Hep G2 Cells; D022781:Hepatocytes / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism*; D006801:Humans; D008247:Lysosomes / Q000378:metabolism; D053078:Membrane Potential, Mitochondrial / Q000187:drug effects; D051381:Rats; D017382:Reactive Oxygen Species / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects; D054852:Small Molecule Libraries / Q000032:analysis / Q000633:toxicity*; D049490:Systems Biology / Q000379:methods*; D013997:Time Factors
D015415:Biomarkers; D017382:Reactive Oxygen Species; D054852:Small Molecule Libraries